Related Experiment Video
Updated: Nov 6, 2025
06:04
Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice
Published on: September 2, 2020
8.5K
Efficacy and safety of Ninjin'yoeito (NYT) in treatment-resistant schizophrenia: Open-Label Study
Tsuyoshi Miyaoka1, Rei Wake2, Tomoko Araki3
1Department of Psychiatry, Shimane University Faculty of Medicine, Izumo-shi, Shimane, Japan; Matsue Aoba Hospital, Matsue-shi, Shimane, Japan.
Asian Journal of Psychiatry
|May 7, 2021
Abstract
No abstract available in PubMed .
More Related Videos
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
1.3K
08:20Author Spotlight: Unveiling the Therapeutic Effects of FSN Treatment – Bridging Research and Clinical Applications in Neuropathic Pain
Published on: June 30, 2023
2.3K
Related Concept Videos
01:28Drug Therapy
135
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
135
01:26Psychosis: Goals of Pharmacotherapy
302
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
302